{"id":"2d080f86-cfd2-4dc8-a409-e2751121b43e","kind":"institutions","code":"UB-I2387","name":"Mingrikaige","nameBasis":"transliterated","summary":"Mingrikaige is an early-stage investment firm.","description":"Mingrikaige is an early-stage investment firm.","country":null,"category":null,"originalName":"明日凯歌","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:20:16.206Z","englishUpdatedAt":"2026-10-15T18:21:16.986Z","reviewedAt":"2026-10-15T18:21:16.986Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3ddab4a94598b28dc690e0626d7cc62f84d812b5efb03d23230a7a4653b935f8","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"明日凯歌是早期投资机构。","sources":[],"related":[{"id":"cc4ebd11-f5cf-4787-86c4-c033abd035f1","kind":"news","code":"cc4ebd11-f5cf-4787-86c4-c033abd035f1","name":"Keyinsai Biotechnology completes equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"科因塞生物完成股权投资融资","eventDate":"2025-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:48:14.211Z","englishUpdatedAt":"2026-10-15T17:35:40.692Z","reviewedAt":"2026-10-15T17:35:40.692Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5ccf449356dce7ea753b886d567667c41491bc2c8e057b56083be76769a57cc6","companyId":"04fa4ebd-226a-444b-bd7d-5c1713fa8eff","foundedYear":null,"logoUrl":null,"path":"/news/cc4ebd11-f5cf-4787-86c4-c033abd035f1"}],"path":"/institutions/mingrikaige","displayName":"明日凯歌","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"明日凯歌 is a venture capital investor based in China (mainland) with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/mingrikaige"}